XELJANZ/XELJANZ XR (tofacitinib) is contraindicated:
- In patients with known hypersensitivity to tofacitinib or any of its components. For a complete listing, see DOSAGE FORMS, COMPOSITION AND PACKAGING section of the product monograph.
- In patients with severe hepatic impairment.
- During pregnancy and breastfeeding.
Social Registration
{* message_almostDone *}
{* message_confirmSocialInformation *}
{* #socialRegistrationForm *}